A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

NCT07371793 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Hemochromatosis

Interventions

DRUG: BBI-001
OTHER: Placebo

Sponsor

Bond Biosciences